Pulsed Dye Laser Treatment — CPB 0559 | AETNA Coverage Update

Aetna modified CPB 0559 governing pulsed dye laser treatment, effective September 26, 2025. Here's what billing teams need to know.

Aetna, a CVS Health company, updated its pulsed dye laser coverage policy under CPB 0559 to define 12 specific medical necessity criteria. This policy covers 29 CPT codes — including CPT 17000–17004, 17106–17111, 17260–17286, and 96920–96922 — across a wide range of dermatologic conditions. If your practice bills pulsed dye laser procedures for Aetna members, review your documentation workflows before September 26, 2025.

Quick-Reference Table

Aetna Pulsed Dye Laser Coverage Criteria and Medical Necessity Requirements 2025

The Aetna pulsed dye laser coverage policy under CPB 0559 sets 12 specific conditions where treatment is considered medically necessary. Each one has its own criteria. Not all conditions qualify automatically — several require proof of prior treatment failure before Aetna will cover pulsed dye laser.

Step therapy is the biggest compliance risk here. For actinic keratoses, members must have failed topical imiquimod or 5-fluorouracil (5-FU), or cryosurgery, before pulsed dye laser qualifies. For genital warts, home therapy with podophyllotoxin or imiquimod must have failed first. For verrucae (warts), at least two conventional therapies must have been tried and failed — topical chemotherapy, curettage, electrodesiccation, and/or cryotherapy.

These step therapy requirements drive claim denial risk. If your documentation doesn't show the failed prior treatments, Aetna will deny the claim. Build that documentation requirement into your intake workflow now, before the September 26 effective date.

For keloids and hypertrophic scars, medical necessity is narrower than you might expect. Coverage applies only when the scar is secondary to an injury or surgical procedure, and only when it either causes significant pain requiring chronic analgesic medication or results in significant functional impairment. A scar that's cosmetically bothersome but doesn't meet one of those two criteria does not qualify.

Port wine stains, hemangiomas, pyogenic granuloma, glomangiomas, and granuloma faciale have more straightforward criteria — but location matters. Coverage for port wine stains, other hemangiomas, pyogenic granuloma, and glomangiomas applies specifically to lesions on the face and neck. Lesions on the trunk or extremities are not covered under these indications.

For angiolymphoid hyperplasia, coverage applies to symptomatic presentations — specifically multiple lesions with pruritus, bleeding, and/or pain — that have failed medical therapies such as oral isotretinoin and steroids. Asymptomatic cases don't qualify.

Mild-to-moderate localized plaque psoriasis is covered, but it requires meeting the additional criteria in CPB 0577 (Laser Treatment for Psoriasis and Other Selected Skin Conditions). If you bill CPT 96920, 96921, or 96922 for psoriasis under an Aetna plan, check CPB 0577 too — this policy doesn't stand alone for that indication.

Prior authorization requirements are not explicitly detailed in the published CPB 0559 criteria, but given the step therapy requirements across multiple indications, plan-level prior auth rules very likely apply. Check Aetna's prior authorization lists for your specific plan codes before scheduling.

Aetna Pulsed Dye Laser Exclusions and Non-Covered Indications

CPB 0559 doesn't publish an explicit experimental/investigational list. But the structure of the policy creates de facto exclusions.

Any pulsed dye laser treatment that doesn't fit one of the 12 covered indications is not medically necessary under this policy. That includes cosmetic applications, conditions not listed, and cases where the covered indication's specific criteria aren't met — such as warts that haven't failed the required conventional therapies, or keloids without documented pain or functional impairment.

Lesion location is also an implicit exclusion trigger. Port wine stains and hemangiomas qualify only for face and neck locations. Glomangiomas qualify only when they're multiple, superficially located, on the face and neck, and surgical excision isn't practical. Billing these codes for other body locations under these diagnoses will likely result in a denial.

Coverage Indications at a Glance

Aetna Pulsed Dye Laser Billing Guidelines and Action Items 2025

Pulsed dye laser billing under CPB 0559 is documentation-heavy. The policy's step therapy requirements mean a clean claim depends on what's in the chart, not just what's billed.

CPT, HCPCS, and ICD-10 Codes for Pulsed Dye Laser Under CPB 0559

CPT Codes Covered for Indications Listed in CPB 0559

CPT Codes Covered When Selection Criteria Are Met

Key ICD-10-CM Diagnosis Codes

Note: The full policy lists 314 ICD-10-CM codes. The codes above represent the published subset available in this policy data. For the complete code list, review CPB 0559 directly on Aetna's clinical policy site or via PayerPolicy.